Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests

Netherlands Journal of Medicine

Volumn 67, Issue 5, 2009, Pages 182-186

  Van Rossum, L G M ^a   Van Rijn, A F ^b   Van Munster, I P ^c   Jansen, J B M J ^a   Fockens, P ^b   Laheij, R J F ^a   Dekker, E ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

Colorectal cancer; Faecal occult blood test; Mass screening; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOCHEMISTRY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PREDICTION; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; GUAIAC; HUMANS; IMMUNOCHEMISTRY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS;

EID: 66449103904     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Slobbe L, Kommer G, Smit J, Groen J, Meerding W, Polder J. Costs of illness in the Netherlands 2003 (Dutch). RIVM report. 2006(270751010).
2. De Gramont A, Tournigand C, Andre T, Larsen AK, Louvet C. Adjuvant therapy for stage II and III colorectal cancer. Semin Oncol. 2007;34(2 Suppl 1):S37-40. (Pubitemid 46590359)
3. Gondos A, Bray F, Brewster DH, et al. Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer. 2008;44:1463-1475
4. Cappell MS. The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps. Med Clinics North Am. 2005;89(1):1-42, vii. (Pubitemid 39441005)
5. Van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82-90.
6. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420-1425 (Pubitemid 39429665)
7. Fenocchi E, Martinez L, Tolve J, et al. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev. 2006;15(5):384-390 (Pubitemid 44252909)
8. Chiang CH, Jeng JE, Wang WM, Jheng BH, Hsu WT, Chen BH. A comparative study of three fecal occult blood tests in upper gastrointestinal bleeding. Kaohsiung J Med Sciences. 2006;22(5):223-228
9. Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Medical Screen. 2002;9(3):99-103. (Pubitemid 35205230)
10. Sohn DK, Jeong SY, Choi HS, et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat. 2005;37(1):20-23
11. Rubeca T, Rapi S, Confortini M, et al. Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC Sensor assays in a consecutive prospective screening series. Int J Biol Markers. 2006;21(3):157-161 (Pubitemid 44660287)
12. Grazzini G, Castiglione G, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev. 2004;13(1):19-26. (Pubitemid 38328115)
13. Vilkin A, Rozen P, Levi Z, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol. 2005;100(11):2519-2525 (Pubitemid 43919686)
14. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Int Med. 2007;146(4):244-255
15. Rockey DC. Occult gastrointestinal bleeding. New Engl J Med. 1999;341(1):38-46. (Pubitemid 29293719)
16. Stroehlein JR, Fairbanks VF, McGill DB, Go VL. Hemoccult detection of fecal occult blood quantitated by radioassay. Am J Dig Dis. 1976;21(10):841-844
17. Huppe D, Hartmann H, Felten G, et al. [Effectiveness of screening colonoscopy in a community-based study]. Gastroenterology. 2008;46(2):193-200.
18. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129(2):422-428 (Pubitemid 41096630)
19. Wexner SD, Brabbee GW, Wichern WA Jr. Sensitivity of hemoccult testing in patients with colorectal carcinoma. Dis Colon Rectum. 1984;27(12):775-776 (Pubitemid 15180497)
20. Fujita M, Sugiyama R, Kumanishi Y, et al. Evaluation of effectiveness of mass screening for colorectal cancer. World J Surg. 1990;14(5):648-52; discussion 52-53 (Pubitemid 20369341)